This is a terrific site that connects webmasters with bloggers and bloggers with viewers! The site is taking me places I could never have imagined…both in the content of the multitude of blogs and in the potential of huge volume on my blog. Check it out!
Archive for April 4th, 2009|Daily archive page
This is great news also…
but they have been treating MI with adult stem cells successfully in thailand, germany, china for almost 10 yrs now. Catch UP! -dg
On March 30, Dr. Roger Gammon, a cardiologist with Austin Heart cardiology group treated the first patient in the world( a 58-year-old Central Texas man) enrolled in a groundbreaking Phase II study. It is one of the nation’s first hospitals to test the new therapy.
The stem cell treatment is administered intravenously and typically takes less than an hour to complete.
The Austin Heart Hospital is one of the 40 hospitals in the nation to conduct this groundbreaking adult stem cell trial, and they are excited enough to lead the way in this important research.
The aim of the study is to test the effectiveness and safety of administering adult stem cells intravenously to repair damaged heart tissue after a heart attack.
patients are injected with donated adult stem cells from the bone marrow of others. The stems cells are purified by Osiris Therapeutics, Inc., which markets them as a product called Prochymal.
Prochymal is being evaluated for its ability to treat heart damage caused by a heart attack. The active ingredient in the new treatment is adult Mesenchymal Stem Cells (MSCs). MSCs have the ability to develop into other types of cells and generate new tissue, including heart muscle.
Patients who are interested to participate in the study must receive the treatment within seven days of a heart attack.
Medical News: ACC: Stem Cell Treatment May Help Repair MI Damage – in Meeting Coverage, ACC from MedPage TodayIn ALL ARTICLES, VICTORIES & SUCCESS STORIES on April 4, 2009 at 2:19 am
This is great news from my alma mater…but they have been treating MI with adult stem cells successfully in thailand, germany, china for almost 10 yrs now. Catch UP! -dg
ACC: Stem Cell Treatment May Help Repair MI Damage
By Todd Neale, Staff Writer, MedPage Today, Published: April 02, 2009
Reviewed by Zalman S. Agus, MD; Emeritus Professor
University of Pennsylvania School of Medicine. Earn CME/CE credit
ORLANDO, April 2 — An infusion of autologous bone marrow progenitor cells may improve outcomes for patients who suffer a severe myocardial infarction, a phase I study suggested.
* Explain to interested patients that the findings come from a phase I study, which is designed to assess safety and feasibility, not efficacy.
* Note that this study was published as an abstract and presented as a poster at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
Patients who received the highest doses of enriched CD34+ endothelial progenitor cells in the affected vessel had increased perfusion of the infarct at six months (P=0.01), according to Arshed Quyyumi, M.D., of Emory University in Atlanta.
This is the first study to find a dose response when using enriched progenitor cells to repair damage following an MI severe enough to cause ventricular remodeling, he said at the American College of Cardiology meeting here…